Antonio Falchi
University of Sassari
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Antonio Falchi.
Clinical Endocrinology | 2006
Giordano Madeddu; Angela Spanu; Francesca Chessa; Giovanna Maria Calia; Carla Lovigu; Patrizia Solinas; Marco Mannazzu; Antonio Falchi; Maria Stella Mura; Giuseppe Madeddu
Objective Given that few and controversial data have been reported on thyroid function in human immunodeficiency virus (HIV) patients on highly active antiretroviral therapy (HAART), we further investigated whether HAART affects thyroid hormones.
Cancer Biotherapy and Radiopharmaceuticals | 2001
Angela Spanu; Dettori G; Francesca Chessa; Alberto Porcu; Pierina Cottu; Patrizia Solinas; Antonio Falchi; Maria E. Solinas; Antonio Mario Scanu; Susanna Nuvoli; Giuseppe Madeddu
We compared 99mTc-Tetrofosmin P-SPECT with radioguided SN biopsy in 101 T1/T2 BC pts to predict axillary lymph node status. The day before surgery all pts underwent lymphoscintigraphy (LS) to mark the SN, following subdermal injection of 99mTc-colloidal sulphur surrounding the breast lesion. LS was combined with pre and intraoperative gamma probe. Previously, all pts had also undergone P-SPECT. ALND was performed in all cases. The SN(s) was detected in 97/101 cases (96%) by LS and gamma probe; in the 4 missed cases P-SPECT predicted lymph node status. In the 97 comparable cases, radioguided SN biopsy showed a slightly higher accuracy than P-SPECT (94.8% vs 93.8%), but a higher false-negative rate (14.3% vs 8.6%); P-SPECT had a higher NPV (95.2% vs 92.5%). The two procedures when combined achieved 100% accuracy. Radioguided SN biopsy alone had 100% accuracy only in pts with BC < 15 mm. P-SPECT had 3 false negative cases, 2 of which were micrometastatic SNs, and 3 false positives. P-SPECT identified 81.2% of cases with a single node, determined the exact number of nodes in 82.6% of cases with 1 to 3 node and correctly classified 93.7% of pts as having < or = 3 or > 3 metastatic nodes. Radioguided SN biopsy seems indicated in selected, early stage, small BC pts, while P-SPECT shows a high sensitivity independent of primary tumor size, giving additional important preoperative prognostic information. The two procedures combined provided a better axillary lymph node status prediction in T1/T2 carcinomas, and could thus improve ALND pt selection.
Quarterly Journal of Nuclear Medicine and Molecular Imaging | 2004
Giordano Madeddu; Angela Spanu; Patrizia Solinas; Giovanna Maria Calia; Carla Lovigu; Francesca Chessa; Marco Mannazzu; Antonio Falchi; Maria Stella Mura; Giuseppe Madeddu
The Journal of Nuclear Medicine | 2003
Orazio Schillaci; Angela Spanu; Francesco Scopinaro; Antonio Falchi; Roberta Danieli; Pietro Marongiu; Nicola Pisu; Giordano Madeddu; Gianfranco Delle Fave; Giuseppe Madeddu
The Journal of Nuclear Medicine | 2004
Angela Spanu; Antonio Falchi; Alessandra Manca; Pietro Marongiu; Antonio Cossu; Nicola Pisu; Francesca Chessa; Susanna Nuvoli; Giuseppe Madeddu
European Journal of Nuclear Medicine and Molecular Imaging | 2001
Angela Spanu; Dettori G; Susanna Nuvoli; Alberto Porcu; Antonio Falchi; Pierina Cottu; Maria E. Solinas; Antonio Mario Scanu; Francesca Chessa; Giuseppe Madeddu
International Journal of Oncology | 2002
Angela Spanu; Orazio Schillaci; Giovanni Battista Meloni; Alberto Porcu; Pierina Cottu; Susanna Nuvoli; Antonio Falchi; Francesca Chessa; Maria E. Solinas; Giuseppe Madeddu
Cancer Biotherapy and Radiopharmaceuticals | 2000
Angela Spanu; Dettori G; P Chiaramida; Pierina Cottu; Antonio Falchi; Alberto Porcu; Maria E. Solinas; Susanna Nuvoli; Giuseppe Madeddu
Nuclear Medicine Communications | 2003
Angela Spanu; Antonio Farris; Orazio Schillaci; Francesca Chessa; M.E. Solinas; Antonio Falchi; Giuseppe Madeddu; S. Nuvoli
International Journal of Oncology | 2003
Angela Spanu; Francesco Ginesu; Pietro Pirina; Maria E. Solinas; Orazio Schillaci; Antonio Farris; Francesca Chessa; Giuseppe Madeddu; Marongiu P; Antonio Falchi; Susanna Nuvoli
